32 results match your criteria: "LSU Health Sciences Center in Shreveport[Affiliation]"
Cancer Sci
February 2013
Department of Pharmacology, Toxicology and Neuroscience, LSU Health Sciences Center in Shreveport, Shreveport, LA, USA.
Withaferin A (WA) is a bioactive compound derived from Withania somnifera. The antitumor activity of WA has been well studied in human cancer models; however, its chemopreventive potential is unclear. In the present study, we used the skin epidermal JB6 P+ cells, a well-established model for tumor promotion, and demonstrated that WA suppressed the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA)-induced cell transformation and cell proliferation.
View Article and Find Full Text PDFApoptosis
March 2011
Department of Pharmacology, Toxicology & Neuroscience, LSU Health Sciences Center in Shreveport, LA 71130, USA.
Increasing evidence has shown that a fraction of the wild-type (wt) form of the tumor suppressor p53, can translocate to mitochondria due to genotoxic stress. The mitochondrial targets of wt p53 have also been studied. However, whether mutant p53, which exists in 50% of human cancers, translocates to mitochondria and affects mitochondrial functions is unclear.
View Article and Find Full Text PDFPLoS One
October 2010
Department of Pharmacology, Toxicology and Neuroscience, LSU Health Sciences Center in Shreveport, Shreveport, Louisiana, United States of America.
The tumor suppressor p53 is known to be able to trigger apoptosis in response to DNA damage, oncogene activation, and certain chemotherapeutic drugs. In addition to its transcriptional activation, a fraction of p53 translocates to mitochondria at the very early stage of apoptosis, which eventually contributes to the loss of mitochondrial membrane potential, generation of reactive oxygen species (ROS), cytochrome c release, and caspase activation. However, the mitochondrial events that affect p53 translocation are still unclear.
View Article and Find Full Text PDFPathophysiology
September 2010
Department of Molecular and Cellular Physiology, LSU Health Sciences Center in Shreveport, 1501 Kings Highway, Shreveport, LA 71130, United States.
J Bacteriol
March 2009
Department of Microbiology and Immunology, LSU Health Sciences Center in Shreveport, Shreveport, Louisiana 71130, USA.
Streptococcus agalactiae (group B Streptococcus [GBS]) remains a leading cause of invasive infections in neonates and has emerged as a pathogen of the immunocompromised and elderly populations. The virulence mechanisms of GBS are relatively understudied and are still poorly understood. Previous evidence indicated that the GBS cspA gene is necessary for full virulence and the cleavage of fibrinogen.
View Article and Find Full Text PDFGastrointest Endosc
March 2006
Gastroenterology and Hepatology, LSU Health Sciences Center in Shreveport, Department of Veteran Affairs, Overton Brooks VA Medical Center, Shreveport, LA 71101, USA.
Surgery
January 2006
Department of Surgery, LSU Health Sciences Center in Shreveport, 1501 Kings Highway, Shreveport, LA 71130, USA.
Background: The rigorous maintenance of normoglycemia by the administration of insulin is beneficial to critically ill patients. Because insulin induces endothelial nitric oxide (NO) release, and the constitutive release of NO maintains normal microvascular permeability, the authors postulated that insulin would prevent peroxide (H(2)O(2))-induced endothelial barrier dysfunction, an effect dependent on endothelial NO synthase (eNOS) activity.
Methods: Murine lung microvascular endothelial cells (LMEC) grown to confluence on 8 micro pore polyethylene filters were exposed to media (control), H(2)O(2) (20 to 500 micromol/L), insulin (1 to 1,000 nmol/L) or insulin (100 nmol/L) + H(2)O(2) (10(-4)mol/L).